Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome

We analyzed the factors and outcome of patients with disseminated adenovirus infection (dAdV) after allogeneic hematopoeitic stem cell transplantation (HSCT). Thirty patients with dAdV were identified among 620 allogeneic HSCT recipients. Primary diseases were leukemia (n=17), Fanconi anemia (n=12) or others (n=1). Source of stem cells was unrelated in 28 and related in 2 patients. The graft consisted of peripheral blood (n=3), bone marrow (n=12) and unrelated cord-blood (UCB, n=15). Risk factors for dAdV in unrelated HSCT recipients were previous Fanconi disease (p=0.03) and GVHD (p=0.02) in children, and cord blood source of stem cells (p=0.029) and GVHD (0.024) in adults.

[1]  N. Kapoor,et al.  Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  J. Sierra,et al.  Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  D. Gao,et al.  Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Petitjean,et al.  Development of a PCR-and hybridization-based assay (PCR Adenovirus Consensus®) for the detection and the species identification of adenoviruses in respiratory specimens , 2004, Journal of Clinical Virology.

[5]  D. Pillay,et al.  Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? , 2000, Bone Marrow Transplantation.

[6]  P. Charache,et al.  Prediction of severe disseminated adenovirus infection by serum PCR , 2001, The Lancet.

[7]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  F. Watzinger,et al.  Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. , 2003, Blood.

[9]  N. Goulden,et al.  Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation , 2000, Bone Marrow Transplantation.

[10]  T. Lion,et al.  Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation , 2006, British journal of haematology.

[11]  A. Toubert,et al.  Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. , 2005, Blood.

[12]  M Pittard,et al.  Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  C. Fegan,et al.  Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. , 2002, Blood.

[14]  D. Srivastava,et al.  Cidofovir for the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplant Patients , 2006, Transplantation.

[15]  M. Horowitz,et al.  Increasing incidence of adenovirus disease in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.

[16]  M. Boeckh,et al.  Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  J. Cayuela,et al.  Effective graft‐versus‐leukaemia effect after allogeneic stem cell transplantation using reduced‐intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia , 2003, British journal of haematology.

[18]  C. Rouzioux,et al.  Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  P. Dahlén,et al.  Detection of adenovirus in clinical specimens by polymerase chain reaction and liquid-phase hybridization quantitated by time-resolved fluorometry , 1993, Journal of clinical microbiology.

[20]  A. S. Wiener,et al.  Transplantation , 1963 .

[21]  J. Wagner,et al.  Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. , 2006, Blood.

[22]  M. Schilham,et al.  Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity , 2005, Bone Marrow Transplantation.

[23]  A. Heim,et al.  Rapid and quantitative detection of human adenovirus DNA by real‐time PCR , 2003, Journal of medical virology.